MyFinsight
Home
Blog
About
Contact
Download
Download image
Net proceeds from
exercise of stock options
$257K
Net cash flows from
financing activities
$257K
Net decrease in cash
and cash...
-$3,609K
Canceled cashflow
$257K
Accrued interest on
convertible debt - related...
$1,831K
Stock-based compensation
expense
$686K
Non-cash interest
expense
$156K
Prepaid expenses and
other assets
-$140K
Net cash from
operating activities
-$3,866K
Canceled cashflow
$2,813K
Net loss
-$5,046K
Change in fair value of
derivative liabilities
-$983K
Accounts payable,
accrued expenses and...
-$662K
Back
Back
Cash Flow
source: myfinsight.com
GALECTIN THERAPEUTICS INC (GALT)
GALECTIN THERAPEUTICS INC (GALT)